Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
Upcoming Luscii - an OMRON Healthcare service webinar: Enabling Exceptional At-home Care for Children
Date: 12 September 2024, 10:30 – 11.15am
They explore the opportunities of technology-enabled paediatric care.
Sign up here.
S-PRO has become a member of SwissICT, the largest professional association for the Information and Communications Technology industry in Switzerland. Read the full article here.
Attendees
Sponsors and
Exhibitors
Agenda
Webinars
Contact us